Aurora Cannabis (NASDAQ:ACB – Get Free Report) is projected to post its quarterly earnings results before the market opens on Wednesday, February 5th. Analysts expect Aurora Cannabis to post earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.
Aurora Cannabis Trading Down 4.5 %
Shares of NASDAQ:ACB opened at $3.65 on Monday. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The business has a 50 day moving average of $4.23 and a two-hundred day moving average of $5.19. The company has a market capitalization of $200.23 million, a PE ratio of -4.80 and a beta of 1.86.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on ACB. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. TD Cowen initiated coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating for the company.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
- Five stocks we like better than Aurora Cannabis
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Conference Calls and Individual Investors
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The Role Economic Reports Play in a Successful Investment Strategy
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.